Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSV Human Challenge in Healthy Adults
NCT02484417Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2015
- Primary completion
- Aug 2016
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
Phase 1, open-label trial of RSV challenge material in respiratory syncytial virus infection (RSV) (3 cohorts), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Adverse Events at Day 56. Started Jul 2015; status: completed.
02
Drugs
RSV challenge material
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT02484417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484417.